Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study

NCT02310100 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02310100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02310100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
January 21, 2015
Completion date
September 17, 2021
Enrollment
178 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation